Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Historian Niall Ferguson warns against unlimited access to AI tools for those under 25, calling it a disaster for brain development.

One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

RXRX is scaling its AI-driven drug discovery technology through billion-dollar pharma deals and strategic tech alliances.

Amazon Web Services on Monday released Kiro, a program that allows developers to write code with help from artificial ...

AI and PLTR are redefining enterprise AI with sharply different strategies. See how their visions for the future stack up.

Onda on Wednesday launched a free ap for surfers that personalizes local weather forecasts and community updates, starting ...

Global health nonprofit PATH navigates U.S. funding freeze as it celebrates the opening of its new Seattle headquarters.

AI is a main theme of second-quarter earnings as Alphabet reports this week. Tesla, Mattel, Hasbro and Coca-Cola also report, ...

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) of an additional ...

The Trump administration should push back against foreign governments enacting policies that undermine American tech ...